For example, in patients with advanced liver cancer, the combined use of DC vaccine and supportive therapy has a lower tumor burden in comparison with patients with supportive therapy alone; meanwhile, the proportion of CD8+ T cells is increased, accompanied by a decreased the level of TGF-β (149). Here, TGFB1 is linked to liver cancer.